[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus]

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Abstract Text:

P M Schneider,A H Hölscher,S Wegerer,U König,K Becker,J R Siewert,

p53 mutations are involved in the pathogenesis of adenocarcinomas in Barrett's esophagus. Our study included patients with histopathologically classified Barrett's cancer and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's cancer. It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections.

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Publishing Authors By Initials

PM Schneider,AH Hölscher,S Wegerer,U König,K Becker,JR Siewert,

For similar proteins: dna-binding proteins: tumor suppressor protein p53 research abstracts see: proteins: dna-binding proteins: tumor suppressor protein p53 research

PUBMED ID PMID:

MEDLINE DATE:

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Langenbecks Archiv für Chirurgie. Supplement. Kong

VOLUME: 115

Page Numbers: 495-9

Journal Abbreviation:

ISSN: 0942-2854

DAY: 20

MONTH: 02

YEAR: 1998

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 9200456

[Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Keywords Mesh Terms:

KEYWORDS: Tumor Suppressor Protein p53

MESH TERMS: genetics

Chemical & Substance for Abstract: [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus] Information

Substance Name: Tumor Suppressor Protein p53

Registry Number: 0

Grant and Affiliation Information for [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus]

AFFILIATION: Chirurgische Klinik, Technischen Universität München.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Langenbecks Arch Chir Suppl Ko

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus Related Publications

• Detection of circulating tumor cells in blood using an optimized density gradient centrifugation.
• Fulminate intracardiac thrombosis associated with Budd-Chiari-syndrome and inferior vena cava thrombosis.
• Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
• Malignant degeneration of Barrett's esophagus: clinical point of view.
• Malignant progression in Barrett's esophagus: pathology and molecular biology.
• Management of early esophageal cancer.
• Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
• Risk analysis in esophageal surgery.
• Stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy.
• Telomere length and hTERT expression in patients with colorectal carcinoma.
• [Ambulatory surgery at the surgical clinic and polyclinic of the Munich Technical University]
• [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus]
• [Combined therapy of inoperable esophageal cancer]
• [Counter-indicated, unnecessary and superfluous surgical methods]
• [Diagnostic procedure in postoperative complications]
• [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?]
• [Gastrointestinal hormones and lower esophageal sphincter]
• [Motility disorders as a pathogenetic principle: esophagus and cardia]
• [Motility disorders as a pathogenetic principle: introduction]
• [Possibilities of telecommunications in surgery]
• [Preoperative risk and postoperative follow-up in surgery of esophageal carcinoma]
• [Principles of radical surgery]
• [R1 resection in the surgery of upper gastrointestinal tumors : Relevance and therapeutic consequences.]
• [Reflux esophagitis from the surgical viewpoint]
• [Severe reflux esophagitis--conservative versus operative treatment. The surgical viewpoint]
• [Technical requirements and possibilities of teleconsultation in laparoscopic interventions]
• [The quality of life of patients with stomach and esophageal cancers]
• [Therapy of esophageal diverticula]
• [Trends in gastroenterologic intensive care medicine: suppurative cholangitis--surgery]
• [Value of clinical and experimental results for general practice in esophageal surgery]